STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation

被引:187
作者
Lee, CK
Raz, R
Gimeno, R
Gertner, R
Wistinghausen, B
Takeshita, K
DePinho, RA
Levy, DE [1 ]
机构
[1] NYU, Sch Med, Dept Pathol, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S1074-7613(02)00336-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
STAT3 has been described as an essential component of G-CSF-driven cell proliferation and granulopoiesis. This notion was tested by conditional gene ablation in transgenic mice. Contrary to expectation, granulocytes developed from STAT3 null bone marrow progenitors, and STAT3 null neutrophils displayed mature effector functions. Rather than a deficit in granulopoiesis, mice lacking STAT3 in their hematopoietic progenitors developed neutrophilia, and bone marrow cells were hyperresponsive to G-CSF stimulation. These studies provide direct evidence for STAT3-independent granulopoiesis and suggest that STAT3 directs a negative feedback loop necessary for controlling neutrophil numbers, possibly through induced expression of the signaling inhibitor, SOCS3.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 45 条
  • [1] Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
    Auernhammer, CJ
    Bousquet, C
    Melmed, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 6964 - 6969
  • [2] Basu S, 2000, BLOOD, V95, P3725
  • [3] Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells
    Boeuf, H
    Hauss, C
    DeGraeve, F
    Baran, N
    Kedinger, C
    [J]. JOURNAL OF CELL BIOLOGY, 1997, 138 (06) : 1207 - 1217
  • [4] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [5] The role of STATs in myeloid differentiation and leukemia
    Coffer, PJ
    Koenderman, L
    de Groot, RP
    [J]. ONCOGENE, 2000, 19 (21) : 2511 - 2522
  • [6] Analysis of C-MYC function in normal cells via conditional gene-targeted mutation
    de Alboran, IM
    O'Hagan, RC
    Gärtner, F
    Malynn, B
    Davidson, L
    Rickert, R
    Rajewsky, K
    DePinho, RA
    Alt, FW
    [J]. IMMUNITY, 2001, 14 (01) : 45 - 55
  • [7] Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease
    Durbin, JE
    Hackenmiller, R
    Simon, MC
    Levy, DE
    [J]. CELL, 1996, 84 (03) : 443 - 450
  • [8] A new protein containing an SH2 domain that inhibits JAK kinases
    Endo, TA
    Masuhara, M
    Yokouchi, M
    Suzuki, R
    Sakamoto, H
    Mitsui, K
    Matsumoto, A
    Tanimura, S
    Ohtsubo, M
    Misawa, H
    Miyazaki, T
    Leonor, N
    Taniguchi, T
    Fujita, T
    Kanakura, Y
    Komiya, S
    Yoshimura, A
    [J]. NATURE, 1997, 387 (6636) : 921 - 924
  • [9] Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene
    Hermans, MHA
    Antonissen, C
    Ward, AC
    Mayen, AEM
    Ploemacher, RE
    Touw, IP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (04) : 683 - 691
  • [10] Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia
    Hermans, MHA
    Ward, AC
    Antonissen, C
    Karis, A
    Löwenberg, B
    Touw, IP
    [J]. BLOOD, 1998, 92 (01) : 32 - 39